Rare diseases
Investigational molecules
Locations
Zone Industrielle Du Brezet, 12 Rue Louis Bleriot, 63100 Clermont Ferrand, France
Research activity includes vernal keratoconjunctivitis, with interest in controlling keratitis, ocular surface inflammation, and symptoms affecting the cornea and surrounding tissues.
Clinical work in this area reflects a focus on chronic immune-mediated eye disorders that can impair comfort, vision, and ocular surface integrity.
Laboratoires Thea runs clinical trials in conditions such as Retinitis pigmentosa, Myopia, Leber's congenital amaurosis, Conjunctivitis allergic, among others.
Clinical trials run by this sponsor – those enrolling participants first.
Safety and Efficacy of Sodium Phenylbutyrate Eye Drops in Children with Myopia
AustriaStudy on the Effectiveness and Safety of Sepofarsen for Patients with Leber Congenital Amaurosis Due to a Specific Genetic Mutation
BelgiumA Study Comparing Tacrolimus and Ciclosporin Eye Drops for Children and Adults with Moderate to Severe Vernal Keratoconjunctivitis
BulgariaStudy on the Effectiveness and Safety of Ultevursen for Patients with Retinitis Pigmentosa Due to USH2A Gene Mutations
FranceStudy of ultevursen treatment in patients with retinitis pigmentosa caused by mutations in USH2A gene exon 13
BelgiumIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
